Back To Search Results

Genetics, Female Gametogenesis

Editor: Prasanna Tadi Updated: 11/4/2022 4:46:23 PM


Female gametogenesis (also referred to as oogenesis) is the process by which diploid (2n) cells undergo cell division through meiosis to form haploid (1n) gametes. A functional understanding of how these haploid cells form in the ovary provides insight into the multitude of pathologies arising from dysfunction during female gametogenesis. The objective of the following article is to discuss the cellular mechanisms behind the formation of haploid gametes, the role and function of haploid gametes formed by female gametogenesis, and the pathophysiology behind the outcomes of incorrect gametogenesis.[1]


Register For Free And Read The Full Article
Get the answers you need instantly with the StatPearls Clinical Decision Support tool. StatPearls spent the last decade developing the largest and most updated Point-of Care resource ever developed. Earn CME/CE by searching and reading articles.
  • Dropdown arrow Search engine and full access to all medical articles
  • Dropdown arrow 10 free questions in your specialty
  • Dropdown arrow Free CME/CE Activities
  • Dropdown arrow Free daily question in your email
  • Dropdown arrow Save favorite articles to your dashboard
  • Dropdown arrow Emails offering discounts

Learn more about a Subscription to StatPearls Point-of-Care


The process of gametogenesis occurs during fetal development, beginning with sexually dimorphic primordial germ cells within the ovaries of the fetus. These primordial germ cells migrate to the genital ridge, where they form oogonia by mitotic proliferation. However, these germ cells are eventually committed to the transition from mitosis to meiosis; this process involves one round of DNA replication followed by two meiotic divisions, aptly named meiosis I and meiosis II. The initiation of meiosis begins with an oocyte containing two homologous copies of each of the 23 chromosomes; one copy is inherited from the father and one copy from the mother. Each of these chromosomes will replicate to form two sister chromatids during the S phase of meiosis I. After the S phase, a phenomenon called meiotic recombination occurs, during which there is the creation of DNA double-strand breaks (DSBs), allowing for the exchange of genetic material between homologous chromosomes. Meiotic recombination serves to increase the genetic diversity of developing gametes as well as form a physical connection that aids in keeping homologous chromosomes together. It is important to note that correct meiotic chromosome segregation is ensured, in part, by the connection maintained between chromatids, which will allow genetic recombination. This connection is maintained from its establishment in prophase I until the eventual separation of homologous chromosomes after metaphase I.[1][2][3][4][5]

In contrast to male gametogenesis, developing female gametes do not proceed directly through to meiosis II. Instead, around the time of birth, the developing oocytes enter a prolonged resting phase during meiotic prophase I called the dictyate. This period can last for decades while the oocyte remains arrested within an ovarian follicle, termed a primary ovarian follicle. At this point, the growing follicle consists of the developing oocyte, one or several layers of surrounding somatic cells called granulosa cells, and an outer rim of specialized cells called theca cells. Gap junctions are also present between the oocyte and the granulosa cells, allowing for the transfer of nutrients and communication via second messenger molecules, contributing to the early stages of follicular maturation (prior to hormonal stimulation).[1][5]

Hormonal stimulation during the adult estrous cycle is also responsible for follicular maturation and the progression of the developing oocyte into meiosis II. Initially, the follicle containing the arrested oocyte responds to stimulation from follicle-stimulating hormone (FSH) secreted by the pituitary gland, which binds to FSH receptors located on the granulosa cells causing the growth and maturation of the follicle into a secondary ovarian follicle. This event marks the beginning of the secondary follicular phase, which further subdivides into a pre-antral and antral phase depending on the timing of the formation of the antrum within the follicle as the granulosa cells and theca cells proliferate. FSH is considered to be the primary driver of antral development within the follicle and will also cause increased expression of luteinizing hormone (LH) receptors in the follicle. Additionally, follicles stimulated by gonadotropins will synthesize steroid hormones such as androgens and estrogens (primarily estradiol), further contributing to follicular development in a paracrine/autocrine fashion. Most importantly, for oocyte maturation, FSH stimulation will lead to the differentiation of granulosa cells into two separate cellular compartments named the cumulus and mural compartments, thus conferring to the arrested oocyte to continue meiosis I until it is arrested again in metaphase II. The growing ovarian follicle becomes stimulated to release the oocyte in response to the surge of LH secreted by the pituitary gland. This surge gives rise to the event of ovulation, during which the follicular wall ruptures, and the cumulus-oocyte complex is released. This event also leads to the formation of luteal cells from the granulosa and theca cells, which serve to secrete estradiol and, primarily, progesterone. The mature oocyte, now arrested in metaphase II, will only go on to complete meiosis II in the event of fertilization by a male spermatozoon, forming a zygote.[6]


The major cellular process behind gametogenesis is meiosis, which involves the division of 1 diploid (2n) cell into four haploid (1n) copies. Meiotic division occurs after DNA replication in oogonia (or spermatogonia). Two meiotic divisions follow DNA replication, neither of which will include additional intervening DNA synthesis. The first division serves to separate homologous chromosome pairs, while the second division will separate the sister chromatids. It is important to note that, in contrast to male gametogenesis, the cytoplasmic divisions are grossly unequal, with one half receiving the vast majority of the cytoplasmic contents and the remaining product (designated polar bodies) receiving a much smaller amount of cytoplasm. This asymmetrical division of resources serves to ensure adequate nutrients for the embryo after fertilization.[7]


The end product of female gametogenesis is a healthy and mature oocyte, which is released from the follicle during ovulation to join with a male gamete through a process called fertilization. The function of the mature oocyte is to provide half of the genetic material to the zygote formed through fertilization, as well as the intracellular components and organelles needed for maturation and future division.[6]


Incorrect gametogenesis can lead to several different pathologies, although an exhaustive discussion is not covered here. It is worth noting that aneuploidy is more common in female gametogenesis despite the higher rate of recombination also seen during female gametogenesis when compared with gametogenesis in males. Errors resulting in aneuploidy, regardless of etiology, will, unsurprisingly, lead to fetal chromosomal abnormalities such as Down Syndrome as well as miscarriage and age-related infertility. Meiosis I, in particular, is associated with age-related increases in chromosomal missegregation. Although aneuploidy, in general, is most likely multi-factorial, the age-related decline in the presence of cohesive molecules holding chromosomes together during meiosis leads to a predisposition of becoming aneuploid via nondisjunction of homologous chromosomes. In rare instances, nutritional defects during the differentiation of oocytes can interfere with their fertilization, causing a hydatidiform mole leading to gestational trophoblastic disease.[1][8][9][10]

Clinical Significance

As discussed above in the section on pathophysiology, there are many clinically significant manifestations of incorrect female gametogenesis. Fetal chromosomal abnormalities, gestational trophoblastic disease, and age-related infertility can all be directly linked back to aberrant gametogenesis within the ovaries.[10][9][8]



MacLennan M,Crichton JH,Playfoot CJ,Adams IR, Oocyte development, meiosis and aneuploidy. Seminars in cell     [PubMed PMID: 26454098]


Herbert M,Kalleas D,Cooney D,Lamb M,Lister L, Meiosis and maternal aging: insights from aneuploid oocytes and trisomy births. Cold Spring Harbor perspectives in biology. 2015 Apr 1;     [PubMed PMID: 25833844]

Level 3 (low-level) evidence


Baudat F,Imai Y,de Massy B, Meiotic recombination in mammals: localization and regulation. Nature reviews. Genetics. 2013 Nov;     [PubMed PMID: 24136506]

Level 3 (low-level) evidence


Revenkova E,Herrmann K,Adelfalk C,Jessberger R, Oocyte cohesin expression restricted to predictyate stages provides full fertility and prevents aneuploidy. Current biology : CB. 2010 Sep 14;     [PubMed PMID: 20817531]

Level 3 (low-level) evidence


Gu L,Liu H,Gu X,Boots C,Moley KH,Wang Q, Metabolic control of oocyte development: linking maternal nutrition and reproductive outcomes. Cellular and molecular life sciences : CMLS. 2015 Jan;     [PubMed PMID: 25280482]


Sánchez F,Smitz J, Molecular control of oogenesis. Biochimica et biophysica acta. 2012 Dec;     [PubMed PMID: 22634430]

Level 3 (low-level) evidence


Bolcun-Filas E,Handel MA, Meiosis: the chromosomal foundation of reproduction. Biology of reproduction. 2018 Jul 1;     [PubMed PMID: 29385397]


Jones KT, Meiosis in oocytes: predisposition to aneuploidy and its increased incidence with age. Human reproduction update. 2008 Mar-Apr;     [PubMed PMID: 18084010]

Level 3 (low-level) evidence


Pacchierotti F,Adler ID,Eichenlaub-Ritter U,Mailhes JB, Gender effects on the incidence of aneuploidy in mammalian germ cells. Environmental research. 2007 May;     [PubMed PMID: 17292877]

Level 3 (low-level) evidence


Candelier JJ, The hydatidiform mole. Cell adhesion     [PubMed PMID: 26421650]